WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2024)
Top medical stocks in 2024 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
OSUR
ORASURE TECHNOLOGIES INC
$453.11M$6.14$7.0014.01%Buy2-52.28%N/AN/AN/A
STAA
STAAR SURGICAL CO
$1.84B$37.70$42.4012.47%Buy510.98%139.79%N/AN/A
ISRG
INTUITIVE SURGICAL INC
$140.97B$400.10$390.00-2.52%Strong Buy1413.96%-1.19%N/AN/A
MMSI
MERIT MEDICAL SYSTEMS INC
$4.37B$75.46$93.7124.19%Buy75.08%67.48%N/AN/A
ALC
ALCON INC
$41.08B$83.28$91.089.36%Buy85.99%32.06%N/AN/A
LMAT
LEMAITRE VASCULAR INC
$1.50B$67.20$64.50-4.02%Buy28.39%9.48%N/AN/A
ATRC
ATRICURE INC
$1.43B$30.14$51.2069.87%Strong Buy515.00%N/AN/AN/A
WST
WEST PHARMACEUTICAL SERVICES INC
$28.89B$394.10$442.7512.34%Strong Buy45.72%25.46%N/AN/A
HOLX
HOLOGIC INC
$18.16B$77.35$82.206.27%Hold53.88%50.45%N/AN/A
UTMD
UTAH MEDICAL PRODUCTS INC
$251.88M$70.18N/AN/AN/AN/AN/AN/AN/AN/A
TFX
TELEFLEX INC
$10.53B$223.87$260.1416.20%Buy75.02%35.89%N/AN/A
RMD
RESMED INC
$28.88B$196.33$198.501.11%Strong Buy84.95%19.13%N/AN/A
HAE
HAEMONETICS CORP
$4.27B$84.09$99.5018.33%Buy23.35%20.43%23.15%9.92%
ATR
APTARGROUP INC
$9.55B$144.66$155.007.15%Strong Buy22.41%10.53%N/AN/A
ATRI
ATRION CORP
$788.41M$448.00N/AN/AN/AN/AN/AN/AN/AN/A
BDX
BECTON DICKINSON & CO
$71.22B$246.53$285.0015.60%Strong Buy45.09%98.26%N/AN/A
COO
COOPER COMPANIES INC
$20.24B$101.84$109.827.84%Strong Buy75.63%77.01%N/AN/A
STVN
STEVANATO GROUP SPA
$9.42B$31.87$32.331.45%Buy38.97%1.00%N/AN/A
EKSO
EKSO BIONICS HOLDINGS INC
$25.42M$1.42$9.25551.41%Buy130.72%N/AN/AN/A
NYXH
NYXOAH SA
$380.22M$13.26$20.6055.35%Strong Buy5177.09%N/AN/AN/A
AKYA
AKOYA BIOSCIENCES INC
$232.44M$4.73$8.7584.99%Strong Buy620.49%N/AN/AN/A
PDEX
PRO DEX INC
$61.13M$17.41N/AN/AN/AN/AN/AN/AN/AN/A
NEPH
NEPHROS INC
$23.93M$2.27$5.00120.26%Buy1N/AN/AN/AN/A
BAX
BAXTER INTERNATIONAL INC
$21.68B$42.69$45.506.58%Buy43.14%-13.86%N/AN/A
EMBC
EMBECTA CORP
$742.77M$12.90$16.0024.03%Strong Sell10.09%111.64%N/AN/A
BNGO
BIONANO GENOMICS INC
$59.62M$1.09$6.00450.46%Buy1119.98%N/AN/AN/A
WRBY
WARBY PARKER INC
$1.57B$13.25$17.2530.19%Buy411.49%N/AN/AN/A
BLFS
BIOLIFE SOLUTIONS INC
$836.24M$18.46N/AN/AN/AN/A10.05%N/AN/AN/A
SMTI
SANARA MEDTECH INC
$321.63M$37.30$44.0017.96%Strong Buy1N/AN/AN/AN/A
OMIC
SINGULAR GENOMICS SYSTEMS INC
$38.22M$0.52$0.6830.56%Hold2-27.86%N/AN/AN/A
RGEN
REPLIGEN CORP
$10.30B$184.75$201.409.01%Strong Buy57.51%154.30%N/AN/A
HBIO
HARVARD BIOSCIENCE INC
$182.28M$4.20N/AN/AN/AN/A5.84%N/AN/AN/A
INFU
INFUSYSTEM HOLDINGS INC
$186.42M$8.80N/AN/AN/AN/AN/AN/AN/AN/A
XRAY
DENTSPLY SIRONA INC
$6.91B$33.31$38.1414.51%Buy72.71%N/AN/AN/A
ANGO
ANGIODYNAMICS INC
$227.17M$5.70$15.00163.16%Strong Buy30.83%N/AN/AN/A
PLSE
PULSE BIOSCIENCES INC
$461.93M$8.40N/AN/AN/AN/AN/AN/AN/AN/A
LUCY
INNOVATIVE EYEWEAR INC
$3.69M$0.29$1.00250.88%Strong Buy1N/AN/AN/AN/A
KRMD
KORU MEDICAL SYSTEMS INC
$103.99M$2.28$3.5053.85%Strong Buy217.73%N/AN/AN/A
AVGR
AVINGER INC
$5.00M$2.94$5.0070.07%Buy132.50%N/AN/AN/A
POCI
PRECISION OPTICS CORPORATION INC
$33.56M$5.53N/AN/AN/AN/AN/AN/AN/AN/A
GCTK
GLUCOTRACK INC
$6.98M$0.33N/AN/AN/AN/AN/AN/AN/AN/A
NXGL
NEXGEL INC
$15.27M$2.67N/AN/AN/AN/AN/AN/AN/AN/A
MHUA
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD
$18.67M$0.78N/AN/AN/AN/AN/AN/AN/AN/A
STSS
SHARPS TECHNOLOGY INC
$5.28M$0.35N/AN/AN/AN/AN/AN/AN/AN/A
FEMY
FEMASYS INC
$31.82M$1.47$10.67625.65%Strong Buy3212.49%N/AN/AN/A
AZTA
AZENTA INC
$3.31B$59.43$74.6725.64%Buy37.75%N/AN/AN/A
POAI
PREDICTIVE ONCOLOGY INC
$11.30M$2.78N/AN/AN/AN/AN/AN/AN/AN/A
ICUI
ICU MEDICAL INC
$2.48B$102.89$123.0019.55%Strong Buy20.71%N/AN/AN/A
BLCO
BAUSCH & LOMB CORP
$6.04B$17.21$18.507.50%Buy67.48%N/AN/AN/A
MLSS
MILESTONE SCIENTIFIC INC
$44.69M$0.63N/AN/AN/AN/AN/AN/AN/AN/A
STXS
STEREOTAXIS INC
$206.14M$2.51$4.5079.28%Strong Buy2N/AN/AN/AN/A
RVP
RETRACTABLE TECHNOLOGIES INC
$35.63M$1.19N/AN/AN/AN/AN/AN/AN/AN/A
MBOT
MICROBOT MEDICAL INC
$16.56M$1.15$8.00595.65%Buy1N/AN/AN/AN/A
NVST
ENVISTA HOLDINGS CORP
$3.70B$21.55$28.3831.67%Buy84.07%N/AN/AN/A
ZTEK
ZENTEK LTD
$119.82M$1.19N/AN/AN/AN/AN/AN/AN/AN/A
ZJYL
JIN MEDICAL INTERNATIONAL LTD
$560.00M$3.50N/AN/AN/AN/AN/AN/AN/AN/A

Medical Stocks FAQ

What are the best medical stocks to buy right now in Mar 2024?

According to Zen Score, the 3 best medical stocks to buy right now are:

1. Orasure Technologies (NASDAQ:OSUR)


Orasure Technologies (NASDAQ:OSUR) is the top medical stock with a Zen Score of 59, which is 28 points higher than the medical industry average of 31. It passed 18 out of 33 due diligence checks and has strong fundamentals. Orasure Technologies has seen its stock return 5.32% over the past year, overperforming other medical stocks by 7 percentage points.

Orasure Technologies has an average 1 year price target of $7.00, an upside of 14.01% from Orasure Technologies's current stock price of $6.14.

Orasure Technologies stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Orasure Technologies, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Staar Surgical Co (NASDAQ:STAA)


Staar Surgical Co (NASDAQ:STAA) is the second best medical stock with a Zen Score of 57, which is 26 points higher than the medical industry average of 31. It passed 19 out of 33 due diligence checks and has strong fundamentals. Staar Surgical Co has seen its stock lose -40.64% over the past year, underperforming other medical stocks by -39 percentage points.

Staar Surgical Co has an average 1 year price target of $42.40, an upside of 12.47% from Staar Surgical Co's current stock price of $37.70.

Staar Surgical Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Staar Surgical Co, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Intuitive Surgical (NASDAQ:ISRG)


Intuitive Surgical (NASDAQ:ISRG) is the third best medical stock with a Zen Score of 52, which is 21 points higher than the medical industry average of 31. It passed 17 out of 33 due diligence checks and has strong fundamentals. Intuitive Surgical has seen its stock return 58.41% over the past year, overperforming other medical stocks by 60 percentage points.

Intuitive Surgical has an average 1 year price target of $390.00, a downside of -2.52% from Intuitive Surgical's current stock price of $400.10.

Intuitive Surgical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 14 analysts covering Intuitive Surgical, 57.14% have issued a Strong Buy rating, 28.57% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 11 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Baxter International (NYSE:BAX)


Baxter International (NYSE:BAX) has an annual dividend yield of 2.72%, which is 1 percentage points higher than the medical industry average of 1.25%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of 22.1% indicates that its dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 2.16%, which is 1 percentage points higher than the medical industry average of 1.25%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -90.3% indicates that its dividend yield might not be sustainable for the long-term.

3. Atrion (NASDAQ:ATRI)


Atrion (NASDAQ:ATRI) has an annual dividend yield of 1.95%, which is 1 percentage points higher than the medical industry average of 1.25%. Atrion's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Atrion's dividend has shown consistent growth over the last 10 years.

Atrion's dividend payout ratio of 78.9% indicates that its dividend yield is sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 1.8% in the last day, and up 1.41% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Orasure Technologies (NASDAQ:OSUR)


Orasure Technologies (NASDAQ:OSUR) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Orasure Technologies has a valuation score of 100, which is 76 points higher than the medical industry average of 24. It passed 7 out of 7 valuation due diligence checks.

Orasure Technologies's stock has gained 5.32% in the past year. It has overperformed other stocks in the medical industry by 7 percentage points.

2. Teleflex (NYSE:TFX)


Teleflex (NYSE:TFX) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Teleflex has a valuation score of 57, which is 33 points higher than the medical industry average of 24. It passed 4 out of 7 valuation due diligence checks.

Teleflex's stock has dropped -9.37% in the past year. It has underperformed other stocks in the medical industry by -7 percentage points.

3. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Embecta has a valuation score of 57, which is 33 points higher than the medical industry average of 24. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -57.72% in the past year. It has underperformed other stocks in the medical industry by -56 percentage points.

Are medical stocks a good buy now?

48.72% of medical stocks rated by analysts are a buy right now. On average, analysts expect medical stocks to rise by 12.45% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 53.29x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.